tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 156 are a HOLD (41.6%), 191 are a BUY (50.93%), 28 are a SELL (7.47%).
Analyst David Risinger, carries an average stock price target met ratio of 70.77% that have a potential upside of 33.94% achieved within 343 days. Previously, David Risinger worked at LEERINK.
David Risinger’s has documented 697 price targets and ratings displayed on 40 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 05-Oct-2026.
Analyst best performing recommendations are on ANAB (ANAPTYSBIO).
The best stock recommendation documented was for ANAB (ANAPTYSBIO) at 4/24/2026. The price target of $66 was fulfilled within 3 days with a profit of $7.12 (12.09%) receiving and performance score of 40.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Feb-2020
$288
$11.53 (4.17%)
$288
Hold Since 06-Jan-2026
$275
$-1.47 (-0.53%)
$260
Buy Since 15-Oct-2020
$300
$23.53 (8.51%)
$280
Buy Since 15-Nov-2023
$290
$13.53 (4.89%)
$285
Buy Since 05-Apr-2022
$310
$33.53 (12.13%)
$278
6 days ago
(06-Oct-2026)
32/34 (94.12%)
$38.64 (14.24%)
496
Which stock is David Risinger most bullish on?
Which stock is David Risinger most reserved on?
